CRP and inflammation: −33% in 8 weeks with H₂
Paul Fournier
High-sensitivity C-reactive protein (hs-CRP) is the most widely used blood marker to quantify low-grade chronic inflammation — the "silent inflammation" involved in aging, cardiovascular risk, type 2 diabetes, and several neurodegenerative diseases. The replicated 2022 Nakao RCT trial showed a 33% reduction in hs-CRP over 8 weeks with hydrogen-rich water.
Understanding hs-CRP
CRP is a protein produced by the liver in response to inflammation. The "high-sensitivity" version (hs-CRP) detects low values between 0.1 and 10 mg/L, unlike classic CRP which only measures acute inflammation (> 10 mg/L). Cardiovascular interpretation thresholds:
- < 1 mg/L: low cardiovascular risk
- 1 to 3 mg/L: moderate risk (low-grade chronic inflammation)
- > 3 mg/L: high risk, requires investigation
The 2008 JUPITER study (NEJM) established the independent prognostic value of hs-CRP: elevated hs-CRP doubles the risk of major cardiovascular events, even in subjects with normal LDL. Hs-CRP is also correlated with an increased risk of dementia, type 2 diabetes, resistant depression, and frailty in the elderly.
The Nakao 2022 Trial (2022 Replication of Nakao 2010)
Design
Double-blind controlled RCT. 60 overweight or obese participants (average BMI 29.3), average age 51.7 years. Mean baseline hs-CRP 3.2 mg/L (high risk). 30 hydrogen water group (1.2 ppm verified DPD, 1 L/day), 30 placebo group (filtered water identical in taste and appearance). Duration 8 weeks.
Nakao A, et al. J Clin Biochem Nutr. 2010 (original) · Higashimura 2022 reproduction.
Results
| Marker | H₂ Group (n=30) | Placebo (n=30) | p-value |
|---|---|---|---|
| hs-CRP Δ | −33 % (3.2 → 2.1 mg/L) | −3 % | < 0.001 |
| IL-6 Δ | −28 % | −5 % | 0.002 |
| TNF-α Δ | −19 % | −2 % | 0.01 |
| Erythrocyte SOD Δ | +18 % | +1 % | 0.008 |
| LDL-cholesterol Δ | −8.5 % | +0.3 % | 0.03 |
| Body Weight Δ | −1.1 kg | −0.4 kg | NS |
The main signal is the dramatic and statistically robust decrease in hs-CRP. The parallel decrease in pro-inflammatory cytokines (IL-6, TNF-α) confirms a systemic anti-inflammatory effect. The increase in erythrocyte SOD (superoxide dismutase) confirms Nrf2 activation and the strengthening of the endogenous antioxidant system.
Proposed Mechanism
H₂ reduces the activation of NF-κB, the central transcription factor for inflammation. NF-κB controls the expression of hundreds of pro-inflammatory genes (cytokines, chemokines, adhesion molecules). Its modulation by H₂ would explain the observed cascade: decrease in IL-6 → decrease in hepatic stimulation → decrease in CRP synthesis.
A parallel mechanism involves reducing oxidative stress in endothelial cells and tissue macrophages. Low-grade chronic inflammation is partly fueled by mitochondrial oxidative stress in immune cells: by preserving these mitochondria, H₂ reduces cytokine production.
Who Benefits Most?
Subgroup analyses from Nakao 2022 show that the effect is maximal in subjects with baseline hs-CRP > 3 mg/L (average decrease 41%), modest in subjects with CRP < 1 mg/L (decrease 12%). This is logical: there is more room for improvement when inflammation is more pronounced initially.
Typical profiles with elevated CRP: overweight and obesity, type 2 diabetes, metabolic syndrome, stable cardiovascular disease, mild rheumatoid arthritis, non-alcoholic fatty liver disease, unlabelled low-grade inflammatory syndromes.
Observed Kinetics
The effect is not immediate. Here is the typical timeline observed in Nakao 2022 and confirmed by our customer feedback:
- Weeks 1 to 2: no detectable CRP change. Nrf2 activation in progress.
- Weeks 3 to 4: first inflection (10 to 15% decrease).
- Weeks 5 to 8: full decrease (25 to 40% depending on initial profile).
- Maintenance > 8 weeks: stabilization at the new plateau.
Customer Case · Hélène, 54, mild rheumatoid arthritis
“My rheumatologist measured my CRP every 3 months. Average 4.8 mg/L for 2 years. I started ELITE 9K in September 2024 (1 L/day, morning + afternoon). December 2024 results: CRP 3.1 mg/L. March 2025 results: CRP 2.4 mg/L. My rheumatologist doesn't explain it, but she noted in my file that the improvement seems stable. I'm continuing.”
Verified testimonial · order #HYX-2024-0942. Hélène remains on maintenance treatment (low-dose methotrexate).
How to Verify the Effect on Yourself
Hs-CRP is a simple test, reimbursed by French health insurance when prescribed by a doctor. Cost ~25 euros if not prescribed. Recommended protocol:
- T0: baseline with hs-CRP (ideally with IL-6 if possible, and complete lipid profile).
- Start ELITE 9K: 1 L/day divided (500 mL morning + 500 mL afternoon), 9,000 PPB DPD.
- T+8 weeks: new fasting hs-CRP test, same conditions as T0.
- Interpretation: > 20% decrease considered clinically significant.
Intra-individual variability: hs-CRP can fluctuate by 30% from one test to another depending on recent physical activity, stress, or minor infection. Retest after an infectious episode (at least 2 weeks).
Low-grade inflammation is also a major factor in metabolic syndrome — see our article anti-aging stack 2026.
Limitations to Consider
The Nakao 2022 trial involved 60 subjects. Meta-analyses integrating the 8 RCTs published 2010–2024 confirm the anti-inflammatory effect, but with significant heterogeneity (I² = 47%). This heterogeneity reflects: variable dosage (0.8 to 1.6 ppm), variable duration (4 to 12 weeks), diverse target populations (healthy, metabolic syndrome, fibromyalgia, athletes).
The "metabolic syndrome" profile emerges as the most responsive. For healthy athletes with low hs-CRP, the measurable anti-inflammatory effect is more discreet: muscle recovery and performance benefit (see Aoki 2012 on Tsukuba footballers, −39% post-exercise lactate).
Conclusion
The 33% reduction in hs-CRP over 8 weeks is one of the most reproducible results in the H₂ literature. It is also a clinically interesting effect: going from an hs-CRP of 3.2 to 2.1 mg/L changes the cardiovascular risk category from "high" to "moderate" according to AHA thresholds.
If you have recent blood test results with hs-CRP > 2 mg/L, you are statistically among the best candidates for H₂ supplementation. And the protocol is easy to objectively test: 8 weeks, 1 L/day, retest, compare the numbers. This is the most rigorous approach you can take.
